Research & Literature

Videoendoscopic Evaluation of Swallowing After Thyroidectomy: 7 and 60 Days.

Arakawa-Sugueno L, Ferraz AR, Morandi J, et al.

Dysphagia 2015; (30(5)):496-505 doi:10.1007/s00455-015-9628-z.

Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer.

Do Cao C, Wémeau JL

Annales d'endocrinologie 2015; (76(1 Suppl 1)):1S47-52.

Concurrent Hypoparathyroidism Is Associated With Impaired Physical Function and Quality of Life in Hypothyroidism.

Sikjaer T, Moser E, Rolighed L, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2016; (31(7)):1440-8 doi:10.1002/jbmr.2812.

Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.

Benvenga S, Di Bari F, Vita R

Endocrine 2017; (56(1)):138-145 doi:10.1007/s12020-017-1244-2.

Subclinical Hyperthyroidism: When to Consider Treatment.

Donangelo I, Suh SY

American family physician 2017; (95(11)):710-716.

Post-treatment surveillance of thyroid cancer.

Wang LY, Ganly I

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2018; (44(3)):357-366 doi:10.1016/j.ejso.2017.07.004.

Stable Isotope Pharmacokinetic Studies Provide Insight into Effects of Age, Sex, and Weight on Levothyroxine Metabolism.

Younis IR, Ahmed MA, Burman KD, et al.

Thyroid : official journal of the American Thyroid Association 2018; (28(1)):41-49 doi:10.1089/thy.2017.0380.

Increased Requirement of Replacement Doses of Levothyroxine Caused by Liver Cirrhosis.

Benvenga S, Capodicasa G, Perelli S, et al.

Frontiers in endocrinology 2018; (9()):150 doi:10.3389/fendo.2018.00150.

Pathophysiological relevance of deiodinase polymorphism.

Bianco AC, Kim BS

Current opinion in endocrinology, diabetes, and obesity 2018; (25(5)):341-346 doi:10.1097/MED.0000000000000428.

Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis.

McAninch EA, Rajan KB, Miller CH, Bianco AC

The Journal of clinical endocrinology and metabolism 2018; doi:10.1210/jc.2018-01361.

L-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia.

Morini E, Catalano A, Lasco A, et al.

Endocrine 2019; (64(2)):284-292 doi:10.1007/s12020-018-1798-7.

Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effects.

Azran C, Porat D, Fine-Shamir N, et al.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2019; (15(2)):333-341 doi:10.1016/j.soard.2019.01.001.

Dynamic risk assessment in patients with differentiated thyroid cancer.

Pitoia F, Jerkovich F

Endocrine-related cancer 2019; (26(10)):R553-R566.

How does thyroidectomy for benign thyroid disease impact upon quality of life? A prospective study.

Chew CR, Chin SL, Lam T, et al.

ANZ journal of surgery 2020; (90(12)):E177-E182 doi:10.1111/ans.16342.

Patient satisfaction and quality of life in hypothyroidism: An online survey by the british thyroid foundation.

Mitchell AL, Hegedüs L, Žarković M, et al.

Clinical endocrinology 2021; (94(3)):513-520 doi:10.1111/cen.14340.

Health-Related Quality of Life in Levothyroxine-Treated Hypothyroid Women and Women without Hypothyroidism: A Case-Control Study.

Romero-Gómez B, Guerrero-Alonso P, Carmona-Torres JM, et al.

Journal of clinical medicine 2020; (9(12)) doi:10.3390/jcm9123864.

Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma.

Lee SJ, Song CM, Ji YB, et al.

Langenbeck's archives of surgery 2021; (406(4)):1223-1231 doi:10.1007/s00423-021-02189-7.

Over-the-counter protein supplement resulting in impaired thyroxine absorption in a hypothyroid patient.

Kumarathunga PADM, Kalupahana NS, Antonypillai CN

Endocrinology, diabetes & metabolism case reports 2021; (2021(21-0070)).

Subclinical hypothyroidism in older individuals.

Biondi B, Cappola AR

The lancet. Diabetes & endocrinology 2022; (10(2)):129-141 doi:10.1016/S2213-8587(21)00285-0.

Primary hypothyroidism and quality of life.

Hegedüs L, Bianco AC, Jonklaas J, et al.

Nature reviews. Endocrinology 2022; (18(4)):230-242 doi:10.1038/s41574-021-00625-8.

Effect of thyrotropin suppressive therapy on lumbar bone mineral density in patients with differentiated thyroid cancer: a retrospective cohort study.

Wang X, Teng R, Liu F, et al.

Gland surgery 2022; (11(2)):432-441 doi:10.21037/gs-22-50.

Thyroid hormone replacement following lobectomy: Long-term institutional analysis 15 years after surgery.

Barranco H, Fazendin J, Lindeman B, et al.

Surgery 2023; (173(1)):189-192 doi:10.1016/j.surg.2022.05.044.

Optimal levothyroxine dose to achieve euthyroidism in patients with primary hypothyroidism: analysis according to etiology.

Ramírez Stieben LA, Pustilnik E, Feldman R, et al.

Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) 2022; (79(4)):353-357 doi:10.31053/1853.0605.v79.n4.35157.

Time to Hypothyroidism Following Hemithyroidectomy.

Abraham CR, Ata A, Stain SC, et al.

Cureus 2022; (14(12)):e32837 doi:10.7759/cureus.32837.

Cardiovascular Outcomes of Differentiated Thyroid Cancer Patients on Long Term TSH Suppression: A Systematic Review and Meta-Analysis.

Yu J, Kaur R, Ayeni FE, et al.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2023; (55(6)):379-387 doi:10.1055/a-2084-3408.

Effect of Thyroid-Stimulating Hormone Suppression Therapy on Cardiac Structure and Function in Patients With Differentiated Thyroid Cancer After Thyroidectomy: A Systematic Review and Meta-Analysis.

Zhang H, Yang Y, Gao C, Tian L

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2024; (30(2)):177-186 doi:10.1016/j.eprac.2023.11.006.

Dynamic risk assessment in patients with differentiated thyroid cancer.

Abelleira E, Jerkovich F

Reviews in endocrine & metabolic disorders 2024; (25(1)):79-93 doi:10.1007/s11154-023-09857-7.

Effects of levothyroxine therapy on bone and mineral metabolism in hypothyroidism: a systematic review and meta-analysis.

Li X, Zhang T, Zhang H, et al.

BMC endocrine disorders 2025; (25(1)):11 doi:10.1186/s12902-024-01819-7.

The role of the hypothalamic-pituitary-thyroid axis in thyroid cancer.

Abaandou L, Ghosh R, Klubo-Gwiezdzinska J

The lancet. Diabetes & endocrinology 2025; (13(4)):333-346 doi:10.1016/S2213-8587(24)00364-4.

Shared Decisionmaking in the Treatment of Hypothyroidism.

Bianco AC

Clinical endocrinology 2025; (103(1)):106-112 doi:10.1111/cen.15228.

Tailoring TSH suppression in differentiated thyroid carcinoma: evidence, controversies, and future directions.

Song X, Zhi X, Qian L

Endocrine 2025; (89(1)):1-19 doi:10.1007/s12020-025-04223-w.

Role of Preoperative Thyroid-Stimulating Hormone Levels in the Prediction of Thyroid Hormone Replacement after Hemithyroidectomy.

Reckziegel RPF, Golbert L, Meyer ELS

International archives of otorhinolaryngology 2025; (29(2)):1-6 doi:10.1055/s-0045-1801852.

Semaglutide therapy and iatrogenic thyrotoxicosis.

Barnett MJL, Eidbo S, Rivadeneira A

Endocrinology, diabetes & metabolism case reports 2025; (2025(3)).

TSH Cutoffs and Recurrence Risk in Differentiated Thyroid Carcinomas: A Systematic Review and Meta-Analysis.

Cho YY, Ahn SH, Kim M, et al.

The Journal of clinical endocrinology and metabolism 2025; (110(12)):3588-3598 doi:10.1210/clinem/dgaf463.

Comparative Study Between the Short-Term Effects of Replacement Therapy with Liquid and Tablet Formulations of Levothyroxine on Insulin Resistance Markers in Recently Thyroidectomized Female Patients.

Baratta F, Moscucci F, Bocale R, et al.

Metabolites 2025; (15(8)) doi:10.3390/metabo15080547.

Effect of Thyroid-Stimulating Hormone Suppression on Bone Mineral Density in Patients with Differentiated Thyroid Carcinoma: A Single Center Retrospective Study.

Jin M, Yoo WS

Journal of bone metabolism 2025; (32(3)):221-231 doi:10.11005/jbm.25.869.

High TSH levels during TSH suppression therapy in DTC postoperative patients are associated with low DIO2 expression in the thyroid and impaired thyroid hormone sensitivity.

Wu J, Huang J, Yan Z, et al.

Frontiers in endocrinology 2025; (16()):1607927 doi:10.3389/fendo.2025.1607927.

Thyroid-Stimulating Hormone Suppression Therapy in Thyroid Cancer: Balancing Benefits and Harms.

Pishdad R, Ahmadi S

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2026; (32(3)):401-405 doi:10.1016/j.eprac.2025.12.002.

Fatigue after Thyroidectomy: A Qualitative Exploration of Patients' Lived Experiences.

Jensen CB, Bacon EM, Xie S, et al.

Thyroid : official journal of the American Thyroid Association 2026; (36(7)):760-769 doi:10.1177/10507256261450430.

Thyroid-Stimulating Hormone Immunoassay Interference Presenting as Treatment-Refractory Hypothyroidism: A Case Report.

Al Ismaili H, Al Kiyumi M

Cureus 2026; (18(5)):e108937 doi:10.7759/cureus.108937.

Quality of life after thyroid surgery: A prospective cohort study with a 12-month follow-up period.

Honkanen J, Molnár K, Moradi A, et al.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 2026; 14574969261458566 doi:10.1177/14574969261458566.

Vertebral fracture risk in patients with differentiated thyroid cancer receiving TSH-suppressive therapy.

Gogas Yavuz D, Dincer Yazan C, Hekimsoy Z, et al.

Endocrine connections 2026; (15(7)) doi:10.1530/EC-26-0103.